Safety, immunogenicity of lyophilized purified vero cell cultured rabies vaccine administered in Zagreb and Essen regimen in post-exposure subjects: A post-marketing, parallel control clinical trial

Safety, immunogenicity of lyophilized purified vero cell cultured rabies vaccine administered in Zagreb and Essen regimen in post-exposure subjects: A post-marketing, parallel control clinical trial

To compare the safety and immunogenicity of lyophilized PVRV under Zagreb and Essen regimen. A post-marketing parallel control clinical trial was conducted. Totally 240 subjects were assigned to two groups randomly, immunized with lyophilized PVRV under Zagreb and Essen schedule. Solicited adverse e...

Full description

Bibliographic Details
Main Authors:	Lei Zhang, Shichun Huang, Li Cai, Zhenggang Zhu, Jian Chen, Sha Lu, Zerong Zhu, Man Zhang, Yuan Fang, Quan Hu
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2021-08-01
Series:	Human Vaccines & Immunotherapeutics
Subjects:	human rabies vaccine lyophilized regimen safety immunogenicity cost-effectiveness
Online Access:	http://dx.doi.org/10.1080/21645515.2021.1880200

Similar Items

Immunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjects
by: Nianmin Shi, et al.
Published: (2017-06-01)

Safety, immunogenicity and immune-persistence of a lyophilized human rabies vaccine (Vero cells) under Zagreb and Essen regimens: a randomized, open-label, controlled phase III clinical trial in healthy participants aged 10–60 years in China
by: Zhenzhen Liang, et al.
Published: (2024-11-01)

Immunogenicity and safety of purified vero cell-cultured rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in the healthy Chinese subjects: a randomized, double-blind, positive controlled phase 3 clinical trial
by: Heng Shen, et al.
Published: (2021-02-01)

Immunogenicity and safety of purified vero cell rabies vaccine (PVRV) produced by Liaoning Cheng Da Co. under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese adults aged 50 and above
by: Jing Wang, et al.
Published: (2017-01-01)

A Randomized, Double-Blind, Controlled Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of a Lyophilized Human Rabies Vaccine (Vero Cells) in Healthy Participants Aged 10–60 Years Following Essen and Zagreb Vaccination Procedures
by: Xiaohong Wu, et al.
Published: (2023-08-01)

Efficacy of Purified Vero Cell Rabies Vaccine (PVRV) under the Zagreb Regimen in Iran
by: Pooneh Rahimi, et al.
Published: (2014-08-01)

A phase 3 clinical trial on the immunogenicity and safety of booster vaccination after Zagreb or Essen regimens
by: Hua-Kun Lv, et al.
Published: (2025-02-01)

Safety and immunogenicity of rabies vaccine as 4 - dose Essen Intramuscular regimen for post exposure prophylaxis: A non - randomized, comparative controlled study
by: Ravish S. Haradanahalli, et al.
Published: (2021-08-01)

Safety and immunogenicity of freeze-dried human rabies vaccines: A phase 3 clinical trial of Zagreb and Essen regimes
by: Jia Li, et al.
Published: (2024-12-01)

Immunogenicity and immune persistence of Zagreb 2-1-1 regimen of rabies vaccine in Chinese healthy individuals: A randomized, parallel-controlled of homologous vaccine with different immune procedure study
by: Li Li, et al.
Published: (2024-12-01)

Development of a new purified vero cell rabies vaccine (Rabivax-S) at the serum institute of India Pvt Ltd
by: Prasad S. Kulkarni, et al.
Published: (2017-04-01)

Pre-marketing immunogenicity and safety of a lyophilized purified human diploid cell rabies vaccine produced from microcarrier cultures: a randomized clinical trial
by: Xingyu Zhou, et al.
Published: (2019-04-01)

Production of Lyophilized Preparation of Anti-Rabies Immunoglobulin and Examination of Its Main Properties
by: E. G. Abramova, et al.
Published: (2011-04-01)

Immunogenicity and safety of WHO-approved TRC-ID regimen with a chromatographically purified Vero cell rabies vaccine with or without rabies immunoglobulin in children
by: Piyada Angsuwatcharakon, et al.
Published: (2018-02-01)

Immunogenicity Persistence of Different Immunization Regimens of Rabies Vaccine in the 10–60 Years Age Group: A Follow-Up Report Based on Phase III Clinical Trial
by: Yunpeng Wang, et al.
Published: (2024-10-01)

Effect of Phone Text Message Reminders on Compliance with Rabies Post-Exposure Prophylaxis following Dog Bites in Rural Kenya
by: Veronicah M. Chuchu, et al.
Published: (2023-06-01)

Immunogenicity and safety of human diploid cell vaccine (HDCV) vs. purified Vero cell vaccine (PVRV) vs. purified chick embryo cell vaccine (PCECV) used in post-exposure prophylaxis: a systematic review and meta-analysis
by: Shi-Yuan Wang, et al.
Published: (2022-01-01)

Purified Vero Cell Rabies Vaccine (PVRV, Verorab<sup>®</sup>): A Systematic Review of Intradermal Use Between 1985 and 2019
by: Thomas Moulenat, et al.
Published: (2020-03-01)

Immunogenicity of 4-dose Essen intramuscular regimen for rabies post-exposure prophylaxis: A multi-center cross-sectional study in China
by: Qisheng Hou, et al.
Published: (2024-07-01)

Rabies post-exposure prophylaxis in the emergency department: A monocentric retrospective observational study
by: Mareen Braunstein, et al.
Published: (2024-09-01)

Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine
by: D.J. Briggs, et al.

Long-term immunity and the effect of one or two booster doses with a lyophilized human rabies vaccine (human diploid cells) at 10 years post primary vaccination in China
by: Jialei Hu, et al.
Published: (2021-09-01)

Development of mRNA rabies vaccines
by: Zixin Fang, et al.
Published: (2024-12-01)

Real-world evidence of rabies post-exposure prophylaxis in Serbia: Nation-wide observational study (2017–2019)
by: Pavle Banović, et al.
Published: (2024-03-01)

Comparison of the immunogenicity and safety of the purified chick embryo cell rabies vaccine manufactured in India and Germany: A randomized, single blind, multicentre, phase IV clinical study
by: Gadey Sampath, et al.
Published: (2017-07-01)

Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10–50 years old: Randomized, blinded, parallel controlled phase III clinical study
by: Xiaoyuan Huang, et al.
Published: (2023-01-01)

Analysis on the risks of severe adverse events in rabies post-exposure prophylaxis and appropriate decision-making procedure
by: Shichun Huang, et al.
Published: (2019-09-01)

Post-exposure prophylaxis (PEP) for rabies with purified chick embryo cell vaccine: a systematic literature review and meta-analysis
by: Scott Preiss, et al.
Published: (2018-06-01)

Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against reindeer rabies
by: Irina Matveeva, et al.
Published: (2022-09-01)

Letter to the editor: Safety and immunogenicity of a novel recombinant rabies vaccine
by: Anurag Agarwal, et al.
Published: (2022-11-01)

Safety and Immunogenicity of a novel three-dose recombinant nanoparticle rabies G protein vaccine administered as simulated post exposure immunization: A randomized, comparator controlled, multicenter, phase III clinical study
by: Ravish H S, et al.
Published: (2021-11-01)

Potency, immunogenicity, and efficacy of rabies vaccine: In vitro and in vivo approach
by: Fahima Akter, et al.
Published: (2024-02-01)

Lyophilization of pharmaceutical products: From concept to reality
by: Krisanin Chansanroj, et al.
Published: (2016-02-01)

Amino Acid Mutation in Position 349 of Glycoprotein Affect the Pathogenicity of Rabies Virus
by: Jun Luo, et al.
Published: (2020-04-01)

A phase III randomized, open-label, non-inferiority clinical trial comparing liquid and lyophilized formulations of oral live attenuated human rotavirus vaccine (HRV) in Indian infants
by: Catherine Cohet, et al.
Published: (2021-11-01)

LYOPHILIZATION EFFECT ON PRODUCTIVITY OF BUTANOL-PRODUCING STRAINS
by: O. O. Tigunova, et al.
Published: (2016-10-01)

Long-Term Immunogenicity and Efficacy of the Oral Rabies Virus Vaccine Strain SPBN GASGAS in Foxes
by: Conrad M. Freuling, et al.
Published: (2019-08-01)

The Effects of Lyophilization on the Physico-Chemical Stability of Sirolimus Liposomes
by: Parvin Zakeri-Milani, et al.
Published: (2013-02-01)

The Incidence of Jackal Bites and Injuries in The Zagreb Anti Rabies Clinic During the 1995-2014 Period
by: Radovan Vodopija, et al.
Published: (2016-01-01)

Rabies post-exposure prophylaxis: A retrospective analysis of timing of initiation and antibody responses in a Belgian cohort
by: Matilde Hens, et al.
Published: (2024-11-01)